Ten years of progress in radiation oncology

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Vordermark, Dirk ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

BRAIN TUMOR; BREAST CANCER; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE GUIDED RADIOTHERAPY; IMAGING SYSTEM; INTENSITY MODULATED RADIATION THERAPY; MOLECULARLY TARGETED THERAPY; NOTE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERSONALIZED MEDICINE; POSITRON EMISSION TOMOGRAPHY; PROTON THERAPY; RADIATION DOSE; RADIOSENSITIVITY; STEREOTACTIC RADIOSURGERY; STEREOTACTIC TREATMENT; TREATMENT PLANNING; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; NEOPLASM; ONCOLOGY; PUBLICATION; RADIOTHERAPY; REVIEW;

HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; PERIODICALS AS TOPIC; RADIATION ONCOLOGY; RADIOTHERAPY; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 82255167665     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-503     Document Type: Note

References (12)

1. Meert AP, Paesmans M, Berghmans T, Martin B, Mascaux C, Vallot F, Verdebout JM, Lafitte JJ, Sculier JP. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001, 1:5. 10.1186/1471-2407-1-5, 34096, 11432756.
2. Thorwarth D, Eschmann SM, Scheiderbauer J, Paulsen F, Alber M. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer 2005, 5:152. 10.1186/1471-2407-5-152, 1325034, 16321146.
3. Kazi A, Godwin G, Simpson J, Sasso G. MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer. BMC Cancer 2010, 10:472. 10.1186/1471-2407-10-472, 2941503, 20809986.
4. Vordermark D, Kölbl O, Ruprecht K, Vince GH, Bratengeier K, Flentje M. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer 2005, 5:55. 10.1186/1471-2407-5-55, 1156875, 15924621.
5. Combs SE, Behnisch W, Kulozik AE, Huber PE, Debus J, Schulz-Ertner D. Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma. BMC Cancer 2007, 7:177. 10.1186/1471-2407-7-177, 2077337, 17854490.
6. Ganswindt U, Paulsen F, Corvin S, Eichhorn K, Glocker S, Hundt I, Birkner M, Alber M, Anastasiadis A, Stenzl A, Bares R, Budach W, Bamberg M, Belka C. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition. BMC Cancer 2005, 5:91. 10.1186/1471-2407-5-91, 1190164, 16048656.
7. Hsieh CH, Kuo YS, Liao LJ, Hu KY, Lin SC, Wu LJ, Lin YC, Chen YJ, Wang LY, Hsieh YP, Lin SL, Chen CY, Chen CA, Shueng PW. Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer. BMC Cancer 2011, 11:37. 10.1186/1471-2407-11-37, 3037924, 21269518.
8. Nikoghosyan AV, Karapanagiotou-Schenkel I, Münter MW, Jensen AD, Combs SE, Debus J. Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study. BMC Cancer 2010, 10:607. 10.1186/1471-2407-10-607, 2988755, 21054824.
9. Rajkumar T, Vijayalakshmi N, Sabitha K, Shirley S, Selvaluxmy G, Bose MV, Nambaru L. A 7 gene expression score predicts for radiation response in cancer cervix. BMC Cancer 2009, 9:365. 10.1186/1471-2407-9-365, 2768747, 19832977.
10. Azria D, Bibeau F, Barbier N, Zouhair A, Lemanski C, Rouanet P, Ychou M, Senesse P, Ozsahin M, Pèlegrin A, Dubois JB, Thèzenas S. Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer. BMC Cancer 2005, 5:62. 10.1186/1471-2407-5-62, 1185521, 15967033.
11. Lee CM, Tannock IF. The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors. BMC Cancer 2010, 10:255. 10.1186/1471-2407-10-255, 2889896, 20525277.
12. Kessler J, Hahnel A, Wichmann H, Rot S, Kappler M, Bache M, Vordermark D. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression. BMC Cancer 2010, 10:605. 10.1186/1471-2407-10-605, 2992520, 21050481.